EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

CAFDIM: A Group Convolution and Self-Attention Fusion-Based Dual-Domain Iterative Method for Sparse-View CT Reconstruction

Jizhong Duan, Chenghong Sun, Haibo Tao, Zhenyu Huang, Yu Liu

Physics in Medicine & Biology · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract Objective. Sparse-view computed tomography (CT) reduces radiation dose and acquisition time by decreasing the number of projection views, but it also makes image reconstruction severely ill-posed, leading to structural distortion and severe artifacts. This study aims to develop an effective reconstruction framework for improving both projection-data fidelity and reconstructed image quality in sparse-view CT. Approach. We propose a group Convolution- and self-Attention Fusion-based Dual-domain Iterative Method (CAFDIM) for sparse-view CT reconstruction. CAFDIM follows a model-informed dual-domain iterative design. The framework consists of the Initialization Enhancement Network (IE-Net), Gradient Update Block (GUB), Projection-domain Repair Network (PR-Net), Image-domain Repair Network(IR-Net), and Momentum Update Block (MUB). The projection-domain branch employs a Deep Sparse Block (DSB) to enhance sparse projection features before full-view projection restoration, while the image-domain branch uses edge-guided residual refinement to improve anatomical structure preservation. To enhance local-global feature representation, a Convolution-Attention Fusion Block (CAFB) is embedded into both repair branches by combining group convolution with Pixel Shift Self-Attention (PSSA). Results. Experiments on simulated and real clinical projection datasets demonstrate that CAFDIM effectively suppresses sparse-view artifacts, preserves anatomical structures, and achieves superior reconstruction accuracy, visual quality, and generalization ability compared with state-of-the-art methods. Significance. CAFDIM provides an effective and efficient dual-domain reconstruction framework for sparse-view CT, showing strong potential for clinical applications in sparse-view and low-dose CT imaging.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Jizhong Duan, Chenghong Sun, Haibo Tao, Zhenyu Huang, Yu Liu
Quelle
Physics in Medicine & Biology
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0031-9155, 1361-6560
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Jizhong Duan, Chenghong Sun, Haibo Tao, Zhenyu Huang, Yu Liu (2026). CAFDIM: A Group Convolution and Self-Attention Fusion-Based Dual-Domain Iterative Method for Sparse-View CT Reconstruction. Physics in Medicine & Biology. https://doi.org/10.1088/1361-6560/aea303
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1 · Lizenz 2